“…Patients with a psychiatric disorder were not more likely to experience failure or subsequent admission. There was no statically significant difference in early or late CAP treatment failure in those with a psychiatric disorder compared with those without (P = 0.3383; P = 0.116). …”
Enlace del recurso
Enlace del recurso

“…Medication prescribed concomitantly with pirfenidone included antihypertensives (54.8%), statins (37.1%) and prophylactic antithrombotics/anticoagulants (36.6%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…P-value and confidence interval were used to measure the level of significance on multivariate analysis and those variables whose P-value < 0.05 were considered as statically significant. RESULTS: The prevalence of early timing of ANC in the study area was 46.8%; with [95% CI 40.5, 51.8]. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Approximately 67.4% of patients used some form of LLT (statin and/or ezetimibe) in the 24 months prior to initiating PCSK9i therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All variables were analyzed using Chi-square test of significance; P < 0.05 was taken as statically significant. RESULT: Of the total 528 patients with TB, 296 was male and 232 were female. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…ACE inhibitors, beta‐blockers, mineralocorticoid receptor antagonists, antiplatelets, statins, and nitrates were less frequently prescribed to women, whereas they more often received digoxin, amiodarone, anticoagulants, and calcium channel blockers. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…MATERIALS AND METHODS: Among adults enrolled in a Medicare Advantage Plan with prescription drug coverage from May 2014 to June 2015, those identified as eligible for the mailing intervention had a late refill for oral antidiabetic medication, statin, angiotensin-converting enzyme inhibitor, or angiotensin receptor blocker medication and were previously unreachable by telephone. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients with familial hypercholesterolemia, nonfamilial hypercholesterolemia, or statin intolerance participated in the trials. The main measure was the degree of concordance or discordance of LDL‐C and Lp(a) in response to PCSK9 inhibition; concordant response was defined as LDL‐C reduction >35% and Lp(a) reduction >10%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Data from 1257 patients with HeFH on maximally tolerated statin ± other lipid-lowering therapies were analyzed by an alirocumab dose regimen and by age subgroups (18 to < 45, 45 to < 55, 55 to < 65, and ≥ 65 years). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Women PD patients had higher aortic AIx values than men (P = 0.039), while lower aortic AIx values were found in PD patients who used statins (P = 0.004). Univariate linear analysis of the aortic AIx values in PD patients showed that systolic blood pressure (P = 0.001), diastolic blood pressure (P = 0.018), and serum sclerostin levels (P = 0.001) were positively correlated, while height (P = 0.018), body weight (P = 0.001), body mass index (P = 0.043), and weekly total creatinine clearance (P = 0.015) were negatively correlated with aortic AIx values in PD patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The highest prescription rate quartile of each medication was associated with a significantly lower mortality compared with the lowest prescription rate quartile (aspirin on admission, incidence rate ratio 0.67 [95% CI 0.61‐0.74], P<0.001; aspirin at discharge, incidence rate ratio 0.50 [95% CI 0.46‐0.55], P<0.001; β‐blocker on admission, 0.83 [0.76‐0.92], P<0.001; β‐blocker at discharge, 0.78 [0.71‐0.85], P<0.001; angiotensin converting enzyme/receptor blocker, 0.68 [0.62‐0.75], P<0.001; statin, 0.63 [0.57‐0.70], P<0.001). The composite prescription score was inversely associated with in‐hospital mortality (β coefficient=−0.48, P<0.001) and was closer to the plateau in the high‐score range (median mortality for composite prescription scores of 6, 15, and 24 were 10.6%, 6.8%, and 4.6%, respectively). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Kidney function decreases during the lifetime, and this decline is a powerful predictor of both kidney and cardiovascular outcomes. Statins lower cardiovascular risk, which may relate to beneficial effects on kidney function. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In multivariate regression analysis, age (OR 0.987, p < 0.001), smoking status (OR 0.190, p < 0.001), use of ASA/NSAIDs (OR 1.652, p = 0.004), and use of statins (OR 0.499 (95%CI 0.295-0.846), p = 0.010) were found significant among H. pylori-positive individuals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The groups showed similar statin use rates at any time in follow-up. The incidence rate of neoplasia and neoplastic mortality was higher in patients with baseline TC or LDL values ≤ median; they showed 85 and 72% increased incidence rate of developing malignancy and 133 and 122% increased incidence rate of neoplastic death respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Data cleaning and analysis was done using SPSS version 25 statistical software. Descriptive statics and bi variable and multivariable logistic regression models were employed to assess the magnitude and factors associated with late initiation of ANC defined as making the first visit after 12 weeks of gestation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Management initially consisted of plasmapheresis to control the acute episode, in addition to lipid lowering agents (Statin, fenofibrate, and omega-3-acid) .despite being on maximal medical therapy, he required plasmapheresis on weekly basis.His physical exam was remarkable for loss of adipose tissue in the lower extremities and excess adipose tissue deposit in the supra-clavicular area. other metabolic complications included severe insulin resistance and difficult to control DM, and NASH that is progressing to chronic liver disease. …”
Enlace del recurso
Enlace del recurso

“…A higher percentage of T2DM HF patients were taking ACE‐inhibitors, beta‐blockers, calcium channel blockers, statins, and diuretics (P values < .05). T2DM HF patients had higher circulating levels of interleukin‐6 (IL‐6) (P < .01), tumor necrosis factor‐alpha (P < .01), and soluble ST2 (sST2) (P < .01) and reported more somatic/affective depressive symptoms (Beck Depression Inventory II) (P < .05) but not cognitive/affective depressive symptoms (P = .20). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The duration of LEAD was 12.3 ± 10.3 years, and 96.9% reported intermittent claudication symptoms. Use of statins was 93% (high-intensity 43%, moderate intensity 49%), renin–angiotensin–aldosterone system inhibitors (75%) and beta-blockers (61%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The time taken to diagnose the patients ranged from <1 year to 12 years with a mean of 4 years. Chronic CH have a statically significant relation with smoking (P = 0.036), older age (P = 0.027), and longer time taken to diagnosis (P = 0.026) compared to episodic CH. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In univariate analysis, the use of statins was implicated with CIPN (p = 0.03–0.04 with different assessments) and diabetes showed a trend (p = 0.09) in the development of CIPN. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso